Anabolic effects and inhibition of interleukin 6 production induced by neridronate on human osteoblasts
Bisphosphonates (BPs) are pharmacological compounds widely used in the treatment of a variety of bone-related diseases, particularly where the bone-turnover is skewed in favour of osteolysis. The mechanisms by which BPs reduce bone-resorption directly acting on osteoclasts (OCs) are now largely clar...
Main Authors: | S. Niccolini, F. Chellini, F. Baldi, P. Ferrata, D. Gambera, C. Capperucci, B. Frediani, A. Spreafico, L. Bocchi, R. Marcolongo |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-09-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/283 |
Similar Items
-
Lanthanum Complex with Neridronic Acid: Synthesis and Properties
by: A. V. Galantsev, et al.
Published: (2019-05-01) -
Clinical development of neridronate: potential for new applications
by: Gatti D, et al.
Published: (2013-04-01) -
Evaluation of Neridronate on the Osseointegration Process of Endeous Titanium Implants in Animal Models
by: D. Berardi, et al.
Published: (2011-05-01) -
A case of mandible Paget’s disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016-12-01) -
Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study
by: L. Guiducci, et al.
Published: (2019-01-01)